EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes

Anna A Kovalenko iD, Maria V Zakharova, Olga E Zubareva, Alexander P Schwarz iD, Yury A Skorik iD, Aleksey V Zaitsev iD

International Journal of Molecular Sciences · 17.09.2025 · 26 (18) · 9054

DOI: 10.3390/ijms26189054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.09.2025. Verfasst von Anna A Kovalenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Mechanisms of Neural Interactions, Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of S…. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Fenofibrate, PPAR alpha, Receptors, Glutamate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temporal lobe epilepsy (TLE) remains pharmacoresistant in 30–40% of patients. Peroxisome proliferator-activated receptor alpha (PPARα) agonists like fenofibrate exhibit anti-inflammatory and neuroprotective properties, but their region-specific effects during epileptogenesis and on behavioral comorbidities are unknown. We investigated fenofibrate (100 mg/kg, 7 days) in the lithium-pilocarpine rat model during the latent phase. Fenofibrate (1) reduced anxiety-like behaviors and improved exploratory deficits; (2) decreased plasma short-chain fatty acids (butyric, pentanoic, hexanoic acids); (3) exerted region-specific modulation of glutamate receptors: restored N-methyl-D-aspartate receptor (NMDAR)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit gene expression in temporal cortex but failed to reverse and further exacerbated the downregulation of AMPAR subunits in the dorsal hippocampus; (4) prevented the upregulation of cortical neuroinflammation markers (reduced Nlrp3, Il1rn); and (5) enhanced the A2 astrocyte marker Ptx3 in the hippocampus while reducing the M2 microglial marker Arg1 in the temporal cortex. No effects on astrogliosis (Gfap), microgliosis (Aif1), or trophic factors (Bdnf, Tgfb1) were observed. This first comprehensive study demonstrates that fenofibrate differentially modulates neuroinflammation and synaptic plasticity across brain regions during epileptogenesis, providing behavioral benefits but highlighting potential hippocampal drawbacks. Its PPARα-mediated actions support further investigation as a complementary strategy for TLE, pending optimization of dosing/timing to mitigate regional disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeFenofibratePPAR alphaReceptors, GlutamateNeuroinflammatory DiseasesAnimalsRatsMaleDisease Models, AnimalBehavior, AnimalHippocampusRats, Sprague-DawleyPilocarpine

Stichwörter der Autor:innen

PPARα agonistbehavioral comorbiditiesdrug repurposingfenofibrateglutamate receptorslatent phaselithium-pilocarpine modelneuroinflammationregion-specific effectstemporal lobe epilepsy

Substanzen

FenofibratePPAR alphaReceptors, GlutamatePilocarpine

Autor:innen und Institutionen

  • Laboratory of Molecular Mechanisms of Neural Interactions, Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, 194223 Saint Petersburg, Russia.
  • Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Branch of Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre «Kurchatov Institute»-Institute of Macromolecular Compounds, 199004 Saint Petersburg, Russia.

ORCID-Profile: Anna A Kovalenko, Alexander P Schwarz, Yury A Skorik, Aleksey V Zaitsev

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Kovalenko, A. A., Zakharova, M. V., Zubareva, O. E., Schwarz, A. P., Skorik, Y. A., & Zaitsev, A. V. (2025). Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes. International Journal of Molecular Sciences, 26(18), 9054. https://doi.org/10.3390/ijms26189054

Vancouver

Kovalenko AA, Zakharova MV, Zubareva OE, Schwarz AP, Skorik YA, Zaitsev AV. Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes. International Journal of Molecular Sciences. 2025;26(18):9054. doi:10.3390/ijms26189054

BibTeX
@article{Kovalenko2025,
  author = {Kovalenko, Anna A and Zakharova, Maria V and Zubareva, Olga E and Schwarz, Alexander P and Skorik, Yury A and Zaitsev, Aleksey V},
  title = {Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {9054},
  doi = {10.3390/ijms26189054}
}
Kostenlos starten →